Sort
89,613 grants matching “depression”
Endowment for Health Disparities Research
$4,338,557Wayne Joseph Riley · Meharry Medical College · S21 · FY2010 · MD
The VITamin D and OmegA-3 TriaL (VITAL)
$4,335,161Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2015 · CA
Los Angeles CRS for the MACS/WIHS Combined Cohort Study
$4,328,387Matthew James Mimiaga · University Of California Los Angeles · U01 · FY2025 · HL
MRI Studies of Brain Function and Metabolism
$4,326,575Daniel Martin Weinberger · National Institute Of Mental Health · Z01 · FY2007 · MH
Los Angeles CRS for the MACS/WIHS Combined Cohort Study
$4,302,308Matthew James Mimiaga · University Of California Los Angeles · U01 · FY2022 · HL
GENERAL CLINICAL RESEARCH CENTER
$4,298,157Philip Pizzo · Stanford University · M01 · FY2006 · RR
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
$4,283,706Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
From Data to Action: Capturing Meaningful Outcomes in Autism Through Harmonized Data
$4,283,587Laura G Klinger · Univ Of North Carolina Chapel Hill · OT2 · FY2025 · OD
Development of (R,R)-dehydronorketamine for treatment resistant depression
$4,270,523Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Continuation of Look AHEAD (Action for Health in Diabetes)Consortium (U01)
$4,262,457Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2013 · DK
Centralized Sequencing Program
$4,239,454Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes
$4,237,687Raquel E Gur · University Of Pennsylvania · RC2 · FY2011 · MH
Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer
$4,236,812David R Freyer · Children'S Hospital Of Los Angeles · R01 · FY2025 · CA
Mechanisms of neural circuit dynamics in working memory and decision-making
$4,221,697Carlos D Brody · Princeton University · U19 · FY2024 · NS
Methocinnamox (MCAM): A novel ÃÂõ-opioid receptor antagonist for opioid use disorders
$4,218,078Charles P France · University Of Texas Hlth Science Center · UH3 · FY2023 · DA
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before
$4,215,002Yael Emilie Bensoussan · University Of South Florida · OT2 · FY2025 · OD
General Clinical Research Center
$4,208,762Gerald S Levey · University Of California Los Angeles · M01 · FY2007 · RR
Antibody-based therapy for fentanyl-related opioid use disorder
$4,202,550Rajeev Indrajit Desai · Mclean Hospital · UG3 · FY2023 · DA
Washington Women's Interagency HIV/AIDS Study
$4,201,485Mary A Young · Georgetown University · U01 · FY2014 · AI
Procurement and Characterization of Postmortem Brain Tissue
$4,200,964Stefano Marenco · National Institute Of Mental Health · ZIC · FY2024 · MH
Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect
$4,198,428Carlos Zarate · National Institute Of Mental Health · ZIA · FY2016 · MH
Mechanisms of neural circuit dynamics in working memory and decision-making
$4,191,637Carlos D Brody · Princeton University · U19 · FY2025 · NS
Understanding the functional impact of cumulative genetic risk in Alzheimer Disease
$4,186,727Suman Jayadev · University Of Washington · RF1 · FY2019 · AG
Integrative Pathways to Health and Illness
$4,176,011Carol D. Ryff · University Of Wisconsin-Madison · P01 · FY2007 · AG
General Clinical Research Center
$4,173,511Philip Pizzo · Stanford University · M01 · FY2007 · RR